Publicacións en colaboración con investigadores/as de Hospital Virgen de la Arrixaca (21)

2024

  1. Real-life data of immune recovery using bictegravir/emtricitabine/ tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 3, pp. 595-607

2023

  1. Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study

    Respiratory research, Vol. 24, Núm. 1, pp. 235

  2. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

    International Journal of COPD, Vol. 18, pp. 1691-1700

  3. Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population

    Archivos de Bronconeumologia, Vol. 59, Núm. 12, pp. 842-845

2022

  1. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  2. The First Steps Towards the Future of ILD: Contributing to Knowledge

    Open Respiratory Archives

  3. With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence

    Archivos de Bronconeumologia

  4. [Translated article] With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence

    Archivos de Bronconeumologia

2021

  1. Silicosis with associated autoimmune findings: Prevalence and differential characteristics

    Medicina Clinica, Vol. 157, Núm. 5, pp. 254-255

2020

  1. Consensus Document on the Diagnosis and Treatment of Chronic Bronchial Infection in Chronic Obstructive Pulmonary Disease

    Archivos de Bronconeumologia, Vol. 56, Núm. 10, pp. 651-664

  2. Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years on

    Archivos de Bronconeumologia, Vol. 56, Núm. 8, pp. 483-492

  3. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

    Respiratory Medicine, Vol. 170

2019

  1. Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study

    Respiratory Medicine, Vol. 151, pp. 49-54

2018

  1. Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience

    Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618

  2. Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience

    Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618

2016

  1. Validation of the 'Test of the Adherence to Inhalers' (TAI) for Asthma and COPD Patients

    Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 29, Núm. 2, pp. 142-152

2014

  1. Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment

    Neurologia

2013

  1. Los costes del ictus en España según su etiología. El protocolo del estudio CONOCES

    Neurologia, Vol. 28, Núm. 6, pp. 332-339

2012

  1. Measurement of asthma control according to global initiative for asthma guidelines: a comparison with the asthma control questionnaire

    Respiratory Research, Vol. 13

2011

  1. Plan de asistencia sanitaria al ICTUS II. 2010

    Neurologia, Vol. 26, Núm. 7, pp. 383-396